About Osmosis Skincare

Osmosis Skincare is dedicated to fostering and maintaining health through a combination of holistic and innovative products that address common problems on a cellular level.

The Osmosis family of products can be grouped into three categories:

Our Product:

  • Pur Medical Skincare
  • Colour Cosmetics
  • Wellness Supplements

Each Osmosis product is based on the belief that the systems of the human body—including its largest organ, the skin—are inherently balanced and self-correcting. Each organ comprises millions of individual cells, which work together to keep the system running smoothly. But when the body is overwhelmed—by excessive sun exposure, environmental pollution, emotional stress—those cells (and systems) can break down. With a targeted approach, they can be brought back into balance, the result of which is vibrant good health: glowing skin, mental clarity, and a healthy body weight.
Achieving Optimal Health, One Cell at a Time

“Beautiful Skin Starts Within”

Osmosis is one of the most scientifically advanced skincare lines available not just because of our remarkable technology but also the fact that our exclusive, patented approach works in partnership with the skin.

One of the most critical aspects of the process of skin rejuvenation is picking the right target. Our ability to address the source of skin conditions is what sets us apart. This is where “holistic therapies rooted in science” was born. Osmosis treats the body as a whole because we understand the connection between the skin and other organs as well as immune system health. Our bodies operate as one unit and it is not efficient or effective to damage or interfere with one aspect of cellular health in order to make gains elsewhere.

Pharmaceutical Grade Liposomal Delivery (patent-pending)

Most skincare does not work because it never makes it to the deep epidermis/dermis. Osmosis uses the same technology as pharmaceutical companies, highly purified, non-gmo phosphatidylcholine liposomes formed in high compression devices to achieve a research proven 600% increase in ingredient delivery.
Zinc Finger Technology U.S. Patent No 8,642,655 B2

All of our cells have zinc fingers working to repair damaged DNA. Osmosis’ Zinc Finger Technology provides the precursors of zinc fingers in a way that kick-starts the body’s repair systems. It is the first visibly evident DNA repair strategy because of the wound repair that ensues after application.
AC-11® DNA Repair Technology U.S. Patent No’s 6,039,949; 6,238,675 B1; 6,361,805 B2; 6,964,784 B2

AC-11 has been shown in human, animal and in-vitro studies to increase DNA repair by up to 40%. This specialized extract of Cat’s Claw contains a class of patented compounds called (Carboxy Alky Esters). In over 30 clinical and scientific research and peer reviewed articles, these actives have shown anti-inflammatory properties, immune system enhancement along with the multiple therapeutic value of DNA repair. Moreover, Optigenex Inc. The manufacturers and patent holders of ac-11®, utilize a specialized extraction methodology known as molecular sieving to remove all the heavy weighted molecules above 10,000 Daltons including but not limited to; alkaloids and tannins. By removing what is commonly referred to among researchers as the (noise) the result is a bio-available extract that is readily absorbed through the large intestine for maximum therapeutic benefit.
Collagen Activation Technology (patent-pending)

Collagen made through damaging the skin is always utilized to repair the newfound damage and never used to add to the dermis. Osmosis developed a unique strategy that combines liposome delivered retinaldehyde, which unlike Retin A, stimulates 1000 times more collagen than retinol without inflaming the skin. We combine this with research proven (non-traumatic) collagen stimulators such as liposomal asiaticoside, chlorella, 1,3 beta glucan, hydroxyproline, niacinamide, and r-lipoic acid.
Skin Nutrition System (patent-pending)

Our skin suffers a decline in circulation each year of our adult life. This reduces the overall food supply of the skin and clearly limits the healing potential and performance of the many skin systems. This is the reason epidermal turnover slows as we age. Liposomal niacinamide gently and effectively dilates dermal blood vessels while stem cell derived growth factors and 1,3 beta glucan-recruited macrophages increase angiogenesis (new blood vessel development) increasing nutrition to the skin.
Stem Cell Growth Factor Technology (patent-pending)

The latest advancement in stem cell derived growth factors is here. Osmosis has exclusive formulas that contain growth factors with exosomes. Exosomes are stem cell-derived coats of armor that protect the life of the GF’s. More importantly however, they also act like a liposome in that they have peptide activators on the outside of the cell to maximize receptor activation. This product was proven to be more efficacious than the leading growth factor serums in a head-to-head comparison.
Protein Oxidation Repair Technology U.S. Patent No 20,130,303,789 A1

Trioxolane is a newly discovered molecule in the skincare industry that dramatically enhances tissue repair by giving the skin the tools it needs to repair protein oxidation. Osmosis understands the importance of preventing protein oxidation with antioxidants. Trioxolane works differently and is a critical tool for the cell’s repair mechanisms that are capable of permanently correcting the damage in the right environment. This technology can create permanent corrections of the dermal-epidermal junction (DEJ) leading to shrinking pores, diminished actinic keratosis and complete clearance of age spots in many cases.
Osmosis Delivers Patented Technology Solutions

Barrier Repair Technology U.S. Patent No 20,130,303,789 A1
Scar Remodeling Technology U.S. Patent No 8,642,655 B2
Capillary Repair Technology U.S. Patent No 8,642,655 B2
Skin Tag Removal Technology U.S. Patent No 8,642,655 B2
Pore Repair Technology U.S. Patent No 20,130,303,789 A1
Melasma Repair Technology U.S. Patent No 20,130,303,789 A1
Age Spot Removal Technology U.S. Patent No 20,130,303,789 A1 Actinic Keratosis Repair Technology U.S. Patent No 8,642,655 B2, 20 ,130,303,789 A1
Non-Acid Peel Technology (patent-pending)
Give Yourself the Gift of Safe Skincare

Osmosis Skincare is proud to be listed as one of the 432 companies setting the bar for safer personal care products. The Campaign for Safe Cosmetics’ recent Market Shift report has bestowed Osmosis Skin Care with “Innovator” status. The Compact for Safe Cosmetics is a voluntary pledge to avoid chemicals that are banned in other countries, to avoid harmful ingredients whenever possible and to fully disclose product ingredients to help consumers make educated choices about what they put in and on their bodies. According to the Campaign for Safe Cosmetics’ website, more than 1,500 companies signed the Compact between 2004 until 2011 when The Campaign for Safe Cosmetics closed the Compact. The research team at Environmental Working Group’s Skin Deep database developed tools for tracking each company’s compliance with the goals of the Compact. These tools were used to determine companies included in The Market Shift report.

The Campaign for Safe Cosmetics is working with the cosmetics industry and lawmakers to pass the Safe Cosmetics Act, which would make it illegal to sell products made with the hazardous chemicals that are currently prevalent in conventional personal care products. For more on Market Shift and to view a list of the companies, visit The Campaign for Safe Cosmetics.